{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:27:54Z","timestamp":1787239674229,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: The most common types of non-malignant prostate diseases are benign prostatic hyperplasia (BPH) and chronic prostatitis (CP). The aim of this study was to find out whether thermobalancing therapy with a physiotherapeutic device is effective for BPH and CP. Methods: During a 2.5-year period, 124 men with BPH over the age of 55 were investigated. Clinical parameters were tested twice: via the International Prostate Symptom Score (IPSS) and via ultrasound measurement of prostate volume (PV) and uroflowmetry maximum flow rate (Qmax), before and after six months of therapy. In 45 men with CP under the age of 55, the dynamics of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) were studied. Results: The results of the investigated index tests in men with BPH confirmed a decrease in IPSS (p &lt; 0.001), a reduction in PV (p &lt; 0.001), an increase in Qmax (p &lt; 0.001), and an improvement of quality of life (QoL) (p &lt; 0.001). NIH-CPSI scores in men with CP indicated positive dynamics. Conclusions: The observed positive changes in IPSS, PV, and Qmax in men with BPH and the improvement in NIH-CPSI-QoL in patients with CP after using a physiotherapeutic device for six months as mono-therapy, support the view that thermobalancing therapy with the device can be recommended for these patients. Furthermore, the therapeutic device is free of side effects.<\/jats:p>","DOI":"10.3390\/diseases4020018","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T10:37:17Z","timestamp":1460975837000},"page":"18","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis"],"prefix":"10.3390","volume":"4","author":[{"given":"Ivan","family":"Aghajanyan","sequence":"first","affiliation":[{"name":"Department of Urology, Yerevan State Medical University, 9 Ezras Hasratyan St, Yerevan 0052, Armenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2273-8439","authenticated-orcid":false,"given":"Simon","family":"Allen","sequence":"additional","affiliation":[{"name":"Fine Treatment, 29 Rewley Road, Oxford OX1 2RA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"key":"ref_1","unstructured":"Epidemiology and Pathogenesis of Benign Prostatic Hyperplasia. Available online: http:\/\/www.uptodate.com\/contents\/epidemiology-and-pathogenesis-of-benign-prostatic-hyperplasia."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.eururo.2015.08.061","article-title":"Contemporary management of chronic prostatitis\/chronic pelvic pain syndrome","volume":"69","author":"Magistro","year":"2016","journal-title":"Eur. Urol."},{"key":"ref_3","first-page":"646","article-title":"Benign prostate hyperplasia with chronic prostatitis: An update","volume":"16","author":"Ma","year":"2010","journal-title":"Zhonghua Nan Ke Xue"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.juro.2011.04.063","article-title":"Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis\/chronic pelvic pain syndrome\u2014A possible link to cardiovascular disease","volume":"186","author":"Shoskes","year":"2011","journal-title":"J. Urol."},{"key":"ref_5","first-page":"147","article-title":"Role of inflammation in benign prostatic hyperplasia","volume":"13","author":"Chughtai","year":"2011","journal-title":"Rev. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MOU.0b013e32835abd4a","article-title":"Correlation between benign prostatic hyperplasia and inflammation","volume":"23","author":"Bostanci","year":"2013","journal-title":"Curr. Opin. Urol."},{"key":"ref_7","first-page":"3015","article-title":"Treatment of prostatitis","volume":"61","author":"Stevermer","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11934-014-0463-9","article-title":"The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy","volume":"15","author":"Ficarra","year":"2014","journal-title":"Curr. Urol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ishiguro, H., and Kawahara, T. (2014). Nonsteroidal anti-inflammatory drugs and prostatic diseases. BioMed Res. Int.","DOI":"10.1155\/2014\/436123"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2012.11559.x","article-title":"Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: Systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Kahokehr","year":"2013","journal-title":"BJU Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ageing\/afs199","article-title":"Guidance on the management of pain in older people","volume":"42","author":"Abdulla","year":"2013","journal-title":"Age Ageing"},{"key":"ref_12","unstructured":"Allen, S., and Adjani, A. (2009). Therapeutic Device and Method. (US 20110152986 A1)."},{"key":"ref_13","first-page":"2371","article-title":"Benign prostatic hyperplasia treatment with new physiotherapeutic device","volume":"12","author":"Allen","year":"2015","journal-title":"Urol. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chung, S.D., and Lin, H.C. (2013). Association between chronic prostatitis\/chronic pelvic pain syndrome and anxiety disorder: A population-based study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064630"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pinto, J.D., He, H.G., Chan, S.W., and Wang, W. (2016). Health-related quality of life and psychological well-being in men with benign prostatic hyperplasia: An integrative review. Jpn. J. Nurs. Sci.","DOI":"10.1111\/jjns.12115"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bju.12745","article-title":"Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)\u2014Focus on the UK","volume":"115","author":"Speakman","year":"2015","journal-title":"BJU Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329456","DOI":"10.1155\/2014\/329456","article-title":"Benign prostatic hyperplasia: A new metabolic disease of the aging male and its correlation with sexual dysfunctions","volume":"2014","author":"Corona","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2013.02.026","article-title":"Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: A comprehensive population study","volume":"64","author":"Lukacs","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/iju.12501","article-title":"Lower urinary tract symptoms, benign prostatic hyperplasia\/benign prostatic enlargement and erectile dysfunction: Are these conditions related to vascular dysfunction?","volume":"21","author":"Shimizu","year":"2014","journal-title":"Int. J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Andersson, K., Nomiya, M., and Yamaguchi, O. (2014). Chronic pelvic ischemia: Contribution to the pathogenesis of lower urinary tract symptoms (LUTS): A new target for pharmacological treatment?. LUTS.","DOI":"10.1111\/luts.12084"},{"key":"ref_21","first-page":"317","article-title":"Abdominal obesity and intra-abdominal pressure: A new paradigm for the pathogenesis of the hypogonadal-obesity-BPH-LUTS connection","volume":"11","author":"Cohen","year":"2012","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOU.0000000000000126","article-title":"New concepts for the treatment of male lower urinary tract symptoms","volume":"25","author":"Hakenberg","year":"2015","journal-title":"Curr. Opin. Urol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S1569-9056(15)30499-1","article-title":"Inflammation in the pathophysiology of benign prostatic hypertrophy","volume":"14","author":"Jack","year":"2015","journal-title":"Eur. Urol. Suppl."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sostres, C., Gargallo, C.J., and Lanas, A. (2013). Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res. Ther., 15.","DOI":"10.1186\/ar4175"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"McGettigan, P., and Henry, D. (2013). Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: An examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001388"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/4\/2\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:22:25Z","timestamp":1760210545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/4\/2\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["diseases4020018"],"URL":"https:\/\/doi.org\/10.3390\/diseases4020018","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,18]]}}}